# Sagimet Biosciences Inc.: Form 8-K, filed Jul 21, 2026

- Company: [Sagimet Biosciences Inc.](/companies/sgmt.md) (CIK 1400118)
- Form: 8-K
- Filed: 2026-07-21
- Accepted by EDGAR: Jul 20, 2026, 21:35 ET
- Period: 2026-07-20
- Accession: 0001193125-26-309334
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1400118/000119312526309334/d141539d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1400118/000119312526309334/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1400118/000119312526309334/d141539d8k.htm

Filed Jul 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-309334. Last ingested by Listed: Nov 12, 2026, 18:04 ET. No prices; not investment advice.
